Dapagliflozin Promising as Add-On Therapy in Young People With Type 2 Diabetes

Dapagliflozin can help children, adolescents and young adults with type 2 diabetes improve their A1c levels when added to other antidiabetes therapies, according to a randomized controlled trial.
Reuters Health Information

source https://www.medscape.com/viewarticle/972292?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?